Search results | NICE

1 result

Sorted by Relevance . Sort by Date

Last 3 months Remove Last 3 months filter
Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
Public health guidelines Remove Public health guidelines filter
Diagnostics guidance Remove Diagnostics guidance filter

Metreleptin for treating lipodystrophy (HST14)

Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults

Type

Highly specialised technologies guidance

Published

24 February 2021
View recommendations for HST14

Show all sections for HST14
Sections for HST14

Overview

1 Recommendations

2 The condition

3 The technology

4 Consideration of the evidence

5 Implementation

6 Evaluation committee members and NICE project team